CVSCX
Price
$16.56
Change
+$0.01 (+0.06%)
Updated
Aug 21 closing price
Net Assets
18.6B
PSCAX
Price
$10.20
Change
-$0.00 (-0.00%)
Updated
Aug 21 closing price
Net Assets
403.42M
Interact to see
Advertisement

CVSCX vs PSCAX

CVSCX vs PSCAX Comparison Chart in %
View a ticker or compare two or three
VS
CVSCX vs. PSCAX commentary
Aug 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVSCX is a StrongBuy and PSCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CVSCX has more cash in the bank: 18.6B vs. PSCAX (403M). PSCAX pays higher dividends than CVSCX: PSCAX (3.42) vs CVSCX (0.78). CVSCX was incepted earlier than PSCAX: CVSCX (27 years) vs PSCAX (14 years). PSCAX (2.31) is less costly to investors than CVSCX (2.01). PSCAX is a more actively managed with annual turnover of: 172.00 vs. CVSCX (43.00). CVSCX (2500) and PSCAX (2500) have matching initial minimum investment requirements. CVSCX annual gain was more profitable for investors over the last year : 5.66 vs. PSCAX (3.75). CVSCX return over 5 years is better than : 16.46 vs. PSCAX (9.99).
CVSCXPSCAXCVSCX / PSCAX
Total Expense Ratio2.011.69119%
Annual Report Gross Expense Ratio2.012.3187%
Fund Existence27 years14 years-
Gain YTD3.5223.64397%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets18.6B403M4,615%
Annual Yield % from dividends0.783.4223%
Returns for 1 year5.663.75151%
Returns for 3 years15.2221.9070%
Returns for 5 years16.469.99165%
Returns for 10 years30.7736.9083%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSOEX17.480.18
+1.04%
Nuveen International Res Eq Retire
TGCEX31.550.19
+0.61%
TCW Concentrated Large Cap Growth I Cl
OEGNX27.490.14
+0.51%
Invesco Discovery Mid Cap Growth R
DRISX23.100.11
+0.48%
North Square Small Cap Value I
PRBRX16.78N/A
N/A
Parnassus International Equity Investor